
CAS 1383539-73-8
:Formule :C19H21N3OS
InChI :InChI=1S/C19H21N3OS/c1-12-7-8-13(2)15(9-12)11-24-19-21-17(14-5-3-4-6-14)16(10-20)18(23)22-19/h7-9,14H,3-6,11H2,1-2H3,(H,21,22,23)
Code InChI :QLLWRTHDHRGHQZ-UHFFFAOYSA-N
SMILES :CC1=CC(=C(C=C1)C)CSC2=NC(=C(C(=O)N2)C#N)C3CCCC3
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
6 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
HJC0197
CAS :HJC0197 is a selective Epac antagonist; blocks cAMP-induced activation with IC50=5.9 μM for Epac2.Formule :C19H21N3OSDegré de pureté :98.05%Couleur et forme :SolidMasse moléculaire :339.4556-Cyclopentyl-2-((2,5-Dimethylbenzyl)Thio)-4-Oxo-1,4-Dihydropyrimidine-5-Carbonitrile
CAS :6-Cyclopentyl-2-((2,5-Dimethylbenzyl)Thio)-4-Oxo-1,4-Dihydropyrimidine-5-CarbonitrileFormule :C19H21N3OSDegré de pureté :99%Masse moléculaire :339.45HJC0197
CAS :6-Cyclopentyl-2-((2,5-dimethylbenzyl)thio)-4-oxo-1,4-dihydropyrimidine-5-carbonitrileFormule :C19H21N3OSDegré de pureté :99%Masse moléculaire :339.45HJC0197
CAS :HJC0197 is a chemical compound that is an analog of the amino acid L-glutamate. It has been shown to regulate camp levels, and has shown to be effective in treating diabetic neuropathy. HJC0197 is also used as a potentiator of anticancer drugs, such as cisplatin, by binding to the cation channel and mitochondrial membrane potential. HJC0197 induces the release of vasoactive intestinal polypeptide (VIP) in hematopoietic cells which leads to increased intracellular calcium concentration. HJC0197 activates toll-like receptor 4 and 5, which are receptors found on the surface of cells that bind to endotoxins and other molecular patterns associated with bacterial infection.Formule :C19H21N3OSDegré de pureté :Min. 95%Masse moléculaire :339.45 g/mol




